| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 47,553 | 107,367 | ||
| Marketable securities | 114,313 | 69,944 | ||
| Prepaid expenses and other current assets | 8,254 | 6,647 | ||
| Total current assets | 170,120 | 183,958 | ||
| Restricted cash and deposits | 768 | 768 | ||
| Right-of-use assets - operating lease | 16,230 | 16,622 | ||
| Other long-term assets | 277 | 185 | ||
| Property and equipment, gross | 9,472 | - | ||
| Lessaccumulated depreciation | 6,843 | - | ||
| Property and equipment, net | 2,629 | 2,864 | ||
| Total assets | 190,024 | 204,397 | ||
| Accounts payable | 1,888 | 1,286 | ||
| Short-term operating lease liability | 3,220 | 3,196 | ||
| Accrued expenses and other current liabilities | 13,715 | 10,370 | ||
| Total current liabilities | 18,823 | 14,852 | ||
| Long-term operating lease liability | 14,534 | 14,916 | ||
| Total liabilities | 33,357 | 29,768 | ||
| Additional paid-in capital | 611,457 | 603,333 | ||
| Accumulated deficit | -454,859 | -428,729 | ||
| Accumulated other comprehensive income | 69 | 25 | ||
| Total stockholders' equity | 156,667 | 174,629 | ||
| Total liabilities and stockholders' equity | 190,024 | 204,397 | ||
Aura Biosciences, Inc. (AURA)
Aura Biosciences, Inc. (AURA)